Razuprotafib Completed Phase 2 Trials for Ocular Hypertension, Primary Open-angle Glaucoma (POAG) / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04405245Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma